Grant: CIHR-ICRH Travel Awards - General pool

Cardiovascular (CV) disease is the leading cause of death in people living with chronic kidney disease (CKD), and males typically have poorer outcomes relative to females. Anti-Müllerian Hormone (AMH) may be linked to CV risk. We studied males with CKD in Calgary, Canada, measuring AMH levels and assessing arterial stiffness as a CV risk predictor. While a trend toward a negative relationship between AMH and CV risk was observed, no significant associations were found. Further research is needed to determine AMH's role in CV disease due to small sample size and the high cardiovascular risk in this population.